ClinicalTrials.gov ID NCT06371235
Sponsor CerbaXpert
Information provided by CerbaXpert (Responsible Party)
Brief Summary
The main objective of the study is to evaluate the frequency of placental transfer of self-Ab directed against the mother’s IFN alpha in the newborn, in all women suffering from a pathology frequently associated with the presence of these autoantibodies and in those seropositive during the pregnancy.